 "Dr Lal PathLabs, Alkem Lab extend rally after stellar debut")
Shares of Dr. Lal PathLabs and Alkem Laboratories continued their upward march, surging by up to 10% on the bourses after making stellar debut on the exchanges on Wednesday.
Diagnostic chain Dr Lal PathLabs has moved higher by 10% to Rs 908 on the BSE, extending its previous day’s 50% rally. On Wednesday, the stock closed at Rs 824 over its issue price of Rs 550.
Drug maker Alkem Laboratories too surged 10.5% at Rs 1,525 on the BSE. Yesterday, the stock closed at Rs 1,381, up 31.5% over its issue price of Rs 1,050 per share.
Alkem Laboratories and Dr Lal PathLabs had managed to mop up Rs 1,350 crore and Rs 632 crore, respectively, through their share sales, which closed on December 10. The issues were subscribed 44 times (Alkem) and 33 times (PathLabs).
At 03:11 p.m. Alkem Laboratories was up 10% at Rs 1,517 while Dr Lal PathLabs up 8% to Rs 893 on the BSE.
Diagnostic chain Dr Lal PathLabs has moved higher by 10% to Rs 908 on the BSE, extending its previous day’s 50% rally. On Wednesday, the stock closed at Rs 824 over its issue price of Rs 550.
Drug maker Alkem Laboratories too surged 10.5% at Rs 1,525 on the BSE. Yesterday, the stock closed at Rs 1,381, up 31.5% over its issue price of Rs 1,050 per share.
Alkem Laboratories and Dr Lal PathLabs had managed to mop up Rs 1,350 crore and Rs 632 crore, respectively, through their share sales, which closed on December 10. The issues were subscribed 44 times (Alkem) and 33 times (PathLabs).
At 03:11 p.m. Alkem Laboratories was up 10% at Rs 1,517 while Dr Lal PathLabs up 8% to Rs 893 on the BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%